International Cannabis Weekly: 448

‘NOT IMMEDIATELY COMPLIANT’: WHAT THE CRS SAYS AMERICA’S RESCHEDULING ORDER ACTUALLY DELIVERS

Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this route have hung over the industry.

READ MORE  »

EXCLUSIVE: CANNABIS GIANTS SUED FOR MARKETING CANNABIS AS MEDICINE

READ MORE »

HIGH TIDE REPORTS RECORD DISTRIBUTION OF 7.6 TONNES OF MEDICAL CANNABIS

READ MORE »

• Curaleaf has become the first UK manufacturer of medical cannabis suppositories and pessaries.
• Why Portugal is losing its status as Europe’s cannabis processing hub, read here.
• Berlin’s Charité is poised to host the seventh Medicinal Cannabis Congress in 2026.
• Medical cannabis dispensing remains complex and labour-intensive work for German pharmacies.
• Curaleaf has completed the buyout of remaining stake in Germany’s Four 20 Pharma.
• Austrian court has ruled on tobacco use with hemp flowers in brand new legal case.
• Germany’s first experimental cannabis store has opened its shutters in Düsseldorf.
• Moldova has set up its hemp framework to help rebuild fibre and seed value chains.
• CSQ launches EU-GMP addendum to support cannabinoid export compliance standards.

USE ICW15 FOR 15% OFF »

• Nabis acquires Hudson Distribution licence to enter New Jersey cannabis market.
• Drug Enforcement Administration has formalised the HHC ban as the Farm Bill offers no market reprieve.
• Pennsylvania Senate panel approves amended bill to regulate cannabis and hemp.
• North Carolina voters could decide on cannabis legalisation under new Senate bill.
• America’s CBD industry now faces same evidential battle Europe has been fighting for 8 years.
• New York opens applications for cannabis farmers markets and pop-up events.
• Blank Rome has added  two new partners to its growing cannabis practice, it has said.
• Ace Venture completes 51% acquisition of Vireo Health New York, it has announced.
• Green Thumb Industries has filed applications for DEA cannabis research registration.

• High Tide reports record quarterly medical cannabis distribution through Remexian Pharma.
• Cannara completes acquisition of Medican Organic to strengthen Canadian cannabis operations.
• Cronos has expanded its Spinach Stix pre-roll products across the Canadian market.
• Organigram is poised to report second quarter fiscal 2026 results on May 12, it says.
• BC Cannabis Secretariat has moved under the Ministry of Agriculture and Food.
• Adastra Holdings appoints new director as company updates cannabis leadership team.
• British Columbia cannabis sales are continuing to climb, according to StatCan data.
• Glow Lifetech has expanded distribution with two major Canadian cannabis retailers.

• CBD softgels are beginning to gain ground with focus on convenience and precise dosing.
• Mexico’s 2026 cannabis march is calling for reform and greater consumer rights on the subject.
• Bolivian demonstrators call for cannabis decriminalisation during public cannabis protest.

• Australian medical cannabis sales are starting to decline as market pressures continue to build.
• Creditors are progressing Cannim recovery plan as doubts emerge over likely returns.

• New museum dedicated to cannabis is poised to open in Cape Town, South Africa.
• Israel moves towards ending smoked medical cannabis under new health policy.
• The Israeli health debate is growing over medical cannabis usage and patient access.